Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00193-6/fulltext?dgcid=hubspot_update_feature_updatealerts_landia&utm_campaign=update-landia&utm_medium=email&_hsmi=277921491&_hsenc=p2ANqtz-_Q8YesbpHB4fM0Piio-tzHNfNvH_L2gWMBduUBoAQqbeunP4hLjR5bRc6HWsETkf1QR_TWX-dOLMDg2QaTIIWClek5lA&utm_content=277697579&utm_source=hs_email